Sarepta Therapeutics
Founded by : James Summerton & Marwan Fawaz, 1 January 1980
About the Company
Sarepta Therapeutics, Inc. is a biotechnology company based in Cambridge, Massachusetts that focuses on developing RNA-targeted therapeutics for the treatment of rare diseases. The company was founded in 1980 as AntiVirals, Inc. and later changed its name to AVI BioPharma, Inc. before becoming Sarepta Therapeutics in 2012.
One of their most notable products is Exondys 51, which was approved by the FDA in 2016 for the treatment of Duchenne muscular dystrophy. Sarepta Therapeutics has also developed gene therapies for other rare diseases such as limb-girdle muscular dystrophy and Charcot-Marie-Tooth disease. The company has partnerships with various pharmaceutical companies and institutions, including Nationwide Children's Hospital and StrideBio, to continue their research and development efforts.
Industry Type
- Sector: Health Care
- Industry group: Health Care Equipment & Services
- Industry: Health Care Providers & Services
- Sub-Industry: Health Care Services
Company Address
Source : Google maps